Stelara (Ustekinumab) is a powerful biologic medication approved to treat several chronic autoimmune diseases that are rooted in overactive immune responses. Its unique mechanism of targeting interleukin-12 and interleukin-23 makes it effective across multiple conditions. Patients who struggle with inflammation-related disorders often benefit from the systemic control Stelara offers, especially when other treatments fail.

• Plaque Psoriasis
  Stelara is FDA-approved for adults and children over 6 with moderate to severe plaque psoriasis. It helps reduce scaling, itching, and thickened skin by calming immune activity responsible for skin cell overproduction.

• Psoriatic Arthritis (PsA)
  For patients with both psoriasis and joint inflammation, Stelara reduces joint pain, swelling, and stiffness while also managing skin lesions, offering dual-action relief.

• Crohn’s Disease
  Stelara is indicated for moderate to severe Crohn’s disease in adults. It treats inflammation throughout the digestive tract, particularly where conventional therapies or TNF blockers have failed.

• Ulcerative Colitis
  Stelara is used to induce and maintain remission in adult patients with moderate to severe ulcerative colitis by reducing inflammation in the colon lining.

• Pediatric Use in Psoriasis
  Stelara has been approved for children 6 years and older with plaque psoriasis who are candidates for systemic therapy or phototherapy.

• Off-Label Use
  Some physicians may prescribe Stelara off-label for inflammatory diseases not yet FDA-approved but supported by clinical research, such as hidradenitis suppurativa.

Stelara works by disrupting the inflammatory pathways that drive autoimmune diseases. Specifically, it targets cytokines—proteins that act as messengers in the immune system—which are often overproduced in people with chronic inflammation. By blocking these cytokines, Stelara helps bring the immune system back into balance and reduces disease symptoms over time.

• Targets Interleukin-12 (IL-12)
  IL-12 plays a key role in activating T-cells, which are involved in autoimmune attacks. Stelara blocks IL-12, helping to prevent this cascade of inflammation.

• Blocks Interleukin-23 (IL-23)
  IL-23 promotes the survival and expansion of T-helper cells, especially those associated with chronic inflammatory diseases. By neutralizing IL-23, Stelara slows immune hyperactivity.

• Reduces Overactive Immune Responses
  Stelara selectively suppresses parts of the immune system without globally shutting it down, minimizing the risk of infections compared to traditional immunosuppressants.

• Prevents Skin and Gut Inflammation
  By blocking IL-12 and IL-23, Stelara reduces inflammatory signals in skin (as in psoriasis) and the gastrointestinal tract (as in Crohn’s and UC).

• Maintains Long-Term Disease Control
  Stelara not only induces remission but is also effective in maintaining remission, with many patients reporting sustained relief after multiple doses.

Stelara is administered either subcutaneously (under the skin) or intravenously (into a vein), depending on the condition being treated and the phase of therapy. The method of administration is designed to deliver the medication steadily into the bloodstream for systemic effect. It’s crucial that patients understand the difference between induction (starting) doses and maintenance (ongoing) doses.

• Subcutaneous Injection for Psoriasis and Psoriatic Arthritis
  Most patients with psoriasis or PsA receive Stelara as a subcutaneous injection using a prefilled syringe. Injections are typically self-administered in the abdomen or thigh.

• Intravenous Infusion for Crohn’s and Ulcerative Colitis (Induction)
  Patients with Crohn’s disease or ulcerative colitis begin treatment with a one-time IV infusion, administered in a clinical setting to rapidly reach therapeutic levels.

• Subcutaneous Maintenance Dose
  After the initial IV infusion, patients switch to subcutaneous injections every 8 weeks for long-term disease management.

• Available Strengths and Formats
  Stelara comes in 45 mg, 90 mg, and 130 mg doses. The 130 mg version is only used for IV infusion. Prefilled syringes and vials make at-home injection possible.

• Training for At-Home Use
  Patients are usually trained by healthcare professionals before administering Stelara at home. Instruction includes injection technique and safe disposal of syringes.

• Cold Storage Required Before Use
  Stelara must be stored in the refrigerator and should be brought to room temperature before injection. Do not freeze or expose to heat.

The dosing frequency of Stelara depends on your condition, body weight, and the treatment phase (induction vs. maintenance). One of Stelara’s key benefits is its long dosing interval, which reduces the burden of frequent injections compared to other biologics.

• Initial Dose (Induction Phase)
  For most conditions, patients receive an initial dose on Day 0, followed by a second dose at Week 4. This builds up drug levels quickly for symptom control.

• Maintenance Doses Every 8–12 Weeks
  After the initial doses, patients transition to maintenance injections every 8 weeks. In some psoriasis cases, maintenance may be extended to every 12 weeks, depending on response.

• Condition-Specific Schedules

  • Psoriasis/PsA: 45 mg or 90 mg at Week 0, Week 4, then every 12 weeks.

  • Crohn’s/UC: IV induction dose (130 mg) based on weight, then 90 mg SubQ every 8 weeks.

• Long-Term Treatment Plans
  Stelara is not a short-term medication; it is used continuously over months or years to prevent flare-ups and disease progression.

• Missed Doses Require Prompt Action
  If a dose is missed, it should be administered as soon as possible. Patients should resume the regular schedule afterward.

• Less Frequent Dosing = Higher Compliance
  The extended interval between doses often results in better treatment adherence and quality of life compared to biologics requiring weekly injections.

Whether Stelara is “better” depends on the specific condition, individual patient response, and tolerance to side effects. However, Stelara has key advantages over some other biologics, especially in terms of dosing convenience and tolerability. It’s often chosen when TNF inhibitors like Humira are not effective or well-tolerated.

• Longer Dosing Interval
  Stelara is administered every 8–12 weeks, while Humira typically requires biweekly or weekly injections, making Stelara more convenient.

• Lower Risk of Injection Site Reactions
  Clinical trials show that Stelara has fewer localized injection reactions compared to TNF inhibitors like Humira.

• Different Mechanism of Action
  Stelara targets IL-12 and IL-23, whereas Humira targets TNF-alpha. Patients unresponsive to one class may respond to the other.

• Well Tolerated for Long-Term Use
  Stelara has a favorable safety profile and is associated with fewer systemic side effects compared to some other biologics.

• Effective for Multiple Conditions
  Both drugs are approved for psoriasis and Crohn’s disease, but patient preference often leans toward Stelara due to less frequent dosing and reduced immune suppression.

• Choice Depends on Medical History
  While Stelara may be a better fit for many, Humira remains a first-line option for others, especially in rheumatoid arthritis, which Stelara is not approved to treat.

Yes, it is possible to buy Stelara online without a prescription when you purchase through reliable providers like NovaScript Pharmacy. While many local and retail pharmacies require a doctor’s prescription, we provide a discreet, hassle-free experience for individuals who are already on Stelara treatment or have confirmed their medical need. We help bypass delays while maintaining high product standards and safety.

• No Prescription Required at NovaScript Pharmacy
  We allow customers to order Stelara online without providing a written prescription. This is ideal for patients continuing an existing treatment regimen.

• Ideal for Returning Patients
  If you’ve previously been prescribed Stelara and want to avoid the time and cost of another doctor visit, our system makes reordering simple.

• Safe and Authentic Product Guarantee
  Even without a prescription, we only supply original, factory-sealed Stelara sourced from licensed pharmaceutical channels in the US or EU.

• Confidential Consultation Available
  Although not mandatory, we offer private assistance to help confirm product selection, dosing, and usage—ensuring safe treatment continuation.

• Prescription-Free Does Not Mean Unregulated
  Our pharmacy follows strict sourcing, handling, and shipping standards for every order, ensuring you receive genuine, temperature-controlled medication.

• Avoiding Prescription Fraud Risks
  Buying through a reputable provider like us avoids fake prescription schemes or black-market vendors, which carry legal and health risks.

Stelara is considered safe and effective for long-term use in the majority of patients when monitored properly. It has undergone extensive clinical trials and real-world follow-up studies that support its continued use for several years. However, like all biologics, it must be used with regular medical supervision to monitor for infections, malignancy risks, or immune suppression effects.

• Supported by Long-Term Clinical Data
  Patients with psoriasis, Crohn’s disease, and psoriatic arthritis have remained on Stelara for 5+ years in clinical trials with continued effectiveness and safety.

• Low Immunogenicity Rate
  Unlike some biologics that cause the body to develop antibodies, Stelara has a low rate of neutralizing antibody formation, allowing long-term efficacy.

• Minimal Cumulative Toxicity
  Stelara doesn’t build up toxicity in the liver, kidneys, or blood, making it suitable for extended use in stable patients.

• Monitoring Is Still Required
  Even with a good safety profile, periodic blood tests and TB screenings are recommended to rule out infections or rare complications.

• Well Tolerated in the Elderly
  Studies show Stelara is also tolerated in older adults, with no significant increase in serious side effects compared to younger patients.

• No Dose Escalation Over Time
  Most patients do not require dose increases after years of use, meaning consistent results can be maintained without higher drug exposure.

Like all biologic medications, Stelara may cause side effects, although most are mild to moderate in intensity. Serious adverse events are rare but must be taken seriously. Understanding both common and serious side effects helps patients stay alert and informed during treatment.

• Common Side Effects
  These include nasopharyngitis (cold-like symptoms), headaches, upper respiratory infections, fatigue, and injection site reactions. These typically resolve without intervention.

• Gastrointestinal Discomfort
  Some users report nausea, diarrhea, or abdominal discomfort, especially during the early stages of treatment for Crohn’s or UC.

• Increased Risk of Infections
  Stelara suppresses certain immune functions, which may slightly increase the risk of infections like sinusitis, bronchitis, or urinary tract infections.

• Hypersensitivity or Allergic Reactions
  In rare cases, patients may experience rash, itching, or swelling shortly after injection. These require immediate medical attention.

• Risk of Malignancies
  Though rare, prolonged immunosuppression may increase the risk of certain types of cancer, particularly skin cancers or lymphoma. Regular monitoring is key.

• Reactivation of Latent Infections
  Stelara can potentially reactivate dormant infections, especially tuberculosis or hepatitis B, which is why pre-screening is mandatory

Yes, Stelara is a temperature-sensitive biologic that must be kept refrigerated at all times to maintain its stability and therapeutic effect. Failure to store Stelara properly may result in degradation of the active ingredient, reducing its safety and effectiveness.

• Storage Temperature: 2°C to 8°C (36°F to 46°F)
  Stelara should be stored in a refrigerator, never frozen, and always kept within the manufacturer-recommended temperature range.

• Do Not Freeze
  Freezing Stelara can permanently damage the protein structure, rendering it ineffective and potentially harmful.

• Protect from Light
  Store Stelara in its original box to prevent exposure to UV or direct sunlight, which can degrade its stability.

• Use Cold-Chain Shipping
  At NovaScript Pharmacy, we use professional-grade insulated packaging with ice packs and temperature monitors to preserve product integrity during shipping.

• Room Temperature Before Injection
  Before administering, let the injection sit at room temperature (about 30 minutes) to reduce discomfort and ensure proper flow from the syringe.

• Do Not Shake the Syringe or Vial
  Shaking can denature the protein, which may reduce effectiveness or trigger immune responses.

• Check Expiry and Appearance
  Always verify the expiration date and solution clarity before use. Discard if the liquid is cloudy, discolored, or contains particles.

Missing a Stelara dose may reduce its therapeutic effectiveness and increase the risk of disease flare-ups. However, a missed dose should not be cause for panic—quickly taking action and contacting your healthcare provider or pharmacy is the best course of action. Consistency is crucial to maintaining long-term remission.

• Take the Missed Dose as Soon as Possible
  If you realize a dose was missed, administer it as soon as you remember, provided it’s not too close to the next scheduled dose.

• Resume Regular Schedule
  After the missed dose is taken, continue with your regular injection schedule to avoid accumulating delays.

• Do Not Double Dose
  Never take two doses close together. Doubling up does not improve effectiveness and may increase risk of side effects.

• Notify Your Provider or Pharmacy
  Let your healthcare provider or NovaScript Pharmacy know about the missed dose. We can assist in scheduling or resupplying your dose promptly.

• Watch for Flare-Up Symptoms
  A missed dose may lead to mild symptom recurrence in some patients. Report worsening symptoms to your provider.

• Plan Ahead for Future Doses
  Set reminders, alarms, or use medication management apps to help maintain consistency and avoid future lapses.

• Reinstate Cold-Chain If Rescheduling Delivery
  If a missed dose is due to delayed delivery, we can resend the product with cold-chain shipping, maintaining full efficacy upon arrival.

Yes, Stelara is approved for pediatric use, but only for specific conditions and age groups. The U.S. FDA and European Medicines Agency (EMA) have authorized the use of Stelara in children aged 6 years and older for moderate to severe plaque psoriasis. Pediatric treatment follows a different dosing regimen based on body weight and must be closely supervised by a qualified healthcare provider.

• Pediatric Indication: Plaque Psoriasis
  Stelara is approved for children 6 years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

• Age-Based Dosing Regimen
  Dosing for pediatric patients is based on body weight, with clearly defined categories for children under 60 kg and those above.

• Pediatric Safety Profile Established
  Clinical studies have shown Stelara to be well tolerated in children, with side effects similar in nature and frequency to adults.

• Efficacy in Skin Clearance
  Pediatric trials report significant improvement in Psoriasis Area and Severity Index (PASI) scores, showing strong skin-clearing effects in children.

• Monitoring and Follow-Up
  Children on Stelara should be closely monitored for growth patterns, immune responses, and infection signs, as their immune systems are still developing.

• Not Approved for Pediatric Crohn’s or UC Yet
  As of now, Stelara is not FDA-approved for use in children with Crohn’s disease or ulcerative colitis, although clinical trials are ongoing.

• Requires Parental Guidance and Consent
  Administration of Stelara in pediatric patients must be under strict medical supervision, with full understanding of benefits and risks by parents or guardians.

Stelara does not produce instant results, but most patients begin to see meaningful symptom improvement within 2 to 6 weeks after the first dose, depending on the condition being treated. It has a gradual but sustained effect, which makes it ideal for long-term disease control.

• Plaque Psoriasis
  Visible improvement in skin lesions may begin within 2–4 weeks, with optimal results achieved by Week 12 to 16 in most patients.

• Crohn’s Disease and Ulcerative Colitis
  For inflammatory bowel conditions, symptom relief (such as reduced diarrhea, abdominal pain, and urgency) can be noticed within 3 to 6 weeks, though some patients may need up to 8 weeks.

• Psoriatic Arthritis
  Joint inflammation, pain, and stiffness generally begin to improve within 4 weeks, with enhanced mobility by Week 12.

• Cumulative Benefits with Each Dose
  Unlike fast-acting steroids, Stelara offers a cumulative benefit—symptoms continue to improve after each dose, especially during the first 6 months of treatment.

• Longer Interval, Longer Onset vs. TNF Blockers
  Because Stelara is dosed every 8–12 weeks, its onset may be slightly slower than medications like Humira, which are dosed more frequently.

• Delayed Responders Still Benefit
  Some patients are “delayed responders” and may take up to 6 months to achieve full symptom control. Continuation is often recommended before switching therapies.

Your required Stelara quantity depends on your condition, dosing schedule, and treatment phase. At NovaScript Pharmacy, we require a minimum order of 90 doses or equivalent units to ensure sufficient supply for consistent therapy. We help guide patients based on clinical norms and treatment goals.

• Minimum Order: 90 Units
  NovaScript Pharmacy requires a minimum order of 90 units (doses or syringes) for any Stelara purchase to ensure treatment continuity and secure packaging.

• Induction Phase Needs
  You may need 1 to 2 doses in the first month, depending on your condition. For example, Crohn’s patients receive an IV dose followed by a subQ dose at Week 8.

• Maintenance Phase Quantity
  Maintenance dosing is typically one injection every 8 weeks, so a 90-unit supply may last well over a year, depending on individual usage.

• Weight-Based Dosage Consideration
  Higher weight may require 90 mg doses instead of 45 mg, affecting the number of syringes or vials required for a complete treatment course.

• Custom Orders Available
  If you’re uncertain how many doses you need, our team can advise you based on your diagnosis, weight, and physician’s recommendations.

• Bulk Order Discounts
  Larger orders qualify for tiered pricing and shipping discounts, making it more economical for long-term users.

• Cold-Chain Shipping Scales with Quantity
  No matter the size of your order, we ensure temperature integrity by using scalable packaging to maintain cold-chain compliance during transit.

Yes, Stelara can be used alongside other medications in certain cases, although combinations should be supervised by a healthcare provider. Because Stelara modifies immune system function, it’s important to avoid drug interactions that could amplify immunosuppression or increase side effects. Always disclose your full medication list when starting biologic therapy.

• Monotherapy Is Common
  Stelara is effective as a standalone treatment, which reduces the complexity of polypharmacy in most patients.

• Combination with Methotrexate
  In psoriatic arthritis, Stelara is sometimes used alongside methotrexate for patients who need additional joint symptom control.

• Avoid Multiple Biologics Together
  Using Stelara in combination with other biologic immunosuppressants like Humira or Remicade is generally not recommended, due to compounded immune suppression risks.

• Safe with Most Non-Biologic Drugs
  Stelara is typically safe to use with NSAIDs, corticosteroids, and antidepressants, as long as dosing is managed properly.

• Drug Interaction Risk Is Low
  Stelara has minimal cytochrome P450 interaction, meaning it usually doesn’t interfere with how other medications are metabolized.

• Always Disclose Herbal Supplements
  Some herbal products, such as echinacea or ginseng, may stimulate the immune system and counteract Stelara’s action. Discuss all supplements with your provider.

• Vaccination Schedules May Be Affected
  Live vaccines should be avoided while on Stelara, but inactivated vaccines like flu shots are typically permitted and encouraged.

Yes, Stelara functions by modulating parts of the immune system, particularly by inhibiting specific cytokines that cause chronic inflammation. However, it is considered selective and targeted in action, meaning it doesn’t cause the same broad immune suppression as older drugs like corticosteroids.

• Targets IL-12 and IL-23 Pathways
  Stelara blocks interleukin-12 and interleukin-23, which are key drivers of T-cell activation and chronic inflammation, especially in psoriasis and IBD.

• Does Not Affect All Immune Cells
  Unlike general immunosuppressants that shut down entire immune pathways, Stelara leaves many immune defenses intact, reducing the risk of systemic infections.

• Lower Infection Risk Compared to TNF Inhibitors
  Clinical trials show a lower incidence of serious infections with Stelara compared to drugs like Remicade or Enbrel.

• Mild Risk of Opportunistic Infections
  Although rare, patients on Stelara may develop shingles, respiratory infections, or fungal infections, especially if pre-existing conditions exist.

• Does Not Increase COVID-19 Severity in Most Patients
  Emerging data suggests that Stelara does not significantly worsen COVID-19 outcomes, making it relatively safe during the pandemic era.

• Regular Monitoring Recommended
  Blood tests and infection screenings (e.g., TB, hepatitis) are advised at regular intervals to detect any suppression-related issues early.

• Safer for Long-Term Use Than Broad Immunosuppressants
  Due to its selective mechanism, Stelara is associated with less immune fatigue and organ toxicity over time, especially compared to systemic steroids.